Can the shelf-life of fixed dose combination artemether-lumefantrine be extended?

Last week a major international health donor had to admit it had lost over two million dollars of medicines and $34 million in cash to corruption. But the situation is worse than publicly acknowledged and is set to deteriorate further.

It is better to require oncologist members of reimbursement committees to ponder trade-offs than to allow those trade-offs to languish in obscurity.

The malaria community has done a great job over the past decade to combat the disease. But this may be about to change.

The United States has been reluctant to purchase and distribute genericAIDS treatments,and this caution has been vindicated.

No fixed-dose combination product has passed FDA-standard approval. Nevertheless, theWorldHealth Organizationhas pre-approved several products for use in Africa.

A significant portion of antimalarial drugs in Africa have been illegally diverted from the public sector, where they were intended to be dispensed free of charge in public health facilities, to the private sector.

An on-the-ground report on how malaria control is going in Uganda.